Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast

• Status: Recruiting
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: Male

Summary

Assessment of the outcomes of prophylaxis with Emicizumab in children with severe hemophilia A in Ivory Coast

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Criteria

Inclusion Criteria: severe hemophilia A with or without inhibitors -

Exclusion Criteria: parents refusal

-